Bob Humphries

Bob Humphries

Non-Executive Director and Strategic Development Advisor

As the Project Head at AstraZeneca, Bob was behind the discovery and early progression of the anti-thrombotic (P2Y12 antagonists) compounds cangrelor and ticagrelor. He is the co- founder of Adhale – a team of Inhalation R&D Consultants that brings together experts in inhalation & intranasal R&D strategy and tactical support. In April 2012, he started his own consultancy – ‘VisionRealisation Ltd’, which aims to help other project teams translate ideas into credible, achievable plans and realise potential opportunities to change patients’ lives. His extensive experience and strategic vision make him an invaluable member of Platelet Solutions.